BIOEX Stock Overview
Bioextrax AB (publ) develops and commercializes a bio-based extraction platform technology.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Bioextrax AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr2.53 |
| 52 Week High | kr7.95 |
| 52 Week Low | kr1.54 |
| Beta | 2.72 |
| 1 Month Change | 27.01% |
| 3 Month Change | 12.69% |
| 1 Year Change | -63.81% |
| 3 Year Change | -89.14% |
| 5 Year Change | n/a |
| Change since IPO | -36.75% |
Recent News & Updates
Recent updates
Shareholder Returns
| BIOEX | SE Machinery | SE Market | |
|---|---|---|---|
| 7D | 7.7% | 1.0% | 0.9% |
| 1Y | -63.8% | 26.5% | 10.3% |
Return vs Industry: BIOEX underperformed the Swedish Machinery industry which returned 26.5% over the past year.
Return vs Market: BIOEX underperformed the Swedish Market which returned 10.3% over the past year.
Price Volatility
| BIOEX volatility | |
|---|---|
| BIOEX Average Weekly Movement | 18.6% |
| Machinery Industry Average Movement | 4.4% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in SE Market | 13.0% |
| 10% least volatile stocks in SE Market | 3.5% |
Stable Share Price: BIOEX's share price has been volatile over the past 3 months.
Volatility Over Time: BIOEX's weekly volatility has increased from 13% to 19% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 13 | Edvard Hall | www.bioextrax.com |
Bioextrax AB (publ) develops and commercializes a bio-based extraction platform technology. It harvests bioplastics (PHA) granules, organic hydrolyzed protein, keratin fibers, bio-oils, protein-rich by products, and amino acids from bacteria. The company was incorporated in 2014 and is based in Lund, Sweden.
Bioextrax AB (publ) Fundamentals Summary
| BIOEX fundamental statistics | |
|---|---|
| Market cap | kr73.96m |
| Earnings (TTM) | -kr21.51m |
| Revenue (TTM) | kr3.01m |
24.6x
P/S Ratio-3.4x
P/E RatioIs BIOEX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BIOEX income statement (TTM) | |
|---|---|
| Revenue | kr3.01m |
| Cost of Revenue | kr1.34m |
| Gross Profit | kr1.67m |
| Other Expenses | kr23.18m |
| Earnings | -kr21.51m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.74 |
| Gross Margin | 55.53% |
| Net Profit Margin | -714.76% |
| Debt/Equity Ratio | 0% |
How did BIOEX perform over the long term?
See historical performance and comparison